Plasma progastrin-releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis-targeted agents in patients with metastatic castration-resistant prostate cancer., Yashi Masahiro;Nishihara Daisaku;Yokoyama Megumi;Fuchizawa Hirotaka;Okazaki Akihito;Takei Kohei;Suzuki Issei;Sakamoto Kazumasa;Kijima Toshiki;Kobayashi Minoru;Kamai Takao, Cancer reports (Hoboken, N.J.), 6(3), e1762, 2022年12月05日